| 1 |
Avacincaptad pegol
| 1件: Avacincaptad pegol Avacincaptad pegol | - | - | - | 1件: 301 301 |
| 2 |
Doconexent
| 2件: Docosahexaenoic acid Docosahexaenoic acid; Docosahexanoic Acid | - | - | - | 10件: 6 6, 46, 48, 49, 90, 94, 113, 240, 299, 301 |
| 3 |
Emixustat
| 1件: Emixustat Emixustat | 1件: D10348
D10348
| - | - | 1件: 301 301 |
| 4 |
Fomepizole
| 1件: 4-Methylpyrazole 4-Methylpyrazole | 1件: D00707
D00707
| 3件: ADH1A ADH1A,
ADH1B,
ADH1C 💬 | 9件: Alcoholic liver disease Alcoholic liver disease, Drug metabolism - cytochrome P450, Fatty acid degradation, Glycolysis / Gluconeogenesis, Metabolic pathways, Metabolism of xenobiotics by cytochrome P450, Pyruvate metabolism, Retinol metabolism, Tyrosine metabolism 💬 | 1件: 301 301 |
| 5 |
Icosapent
| 2件: Eicosapentaenoic acid Eicosapentaenoic acid; Icosapent | 1件: D08061
D08061
| - | - | 11件: 8 8, 46, 48, 49, 96, 97, 113, 296, 297, 301, 338 |
| 6 |
Interferon Gamma
| 1件: Interferon Gamma Interferon Gamma | - | - | - | 8件: 18 18, 65, 85, 107, 228, 299, 301, 326 |
| 7 |
Interferon gamma-1b
| 2件: ACTIMMUNE ACTIMMUNE; INTERFERON GAMMA-1B | 1件: D00747
D00747
| 2件: IFNGR1 IFNGR1,
IFNGR2 💬 | 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 7件: 18 18, 65, 85, 228, 299, 301, 326 |
| 8 |
Metformin
| 5件: Metformin Metformin; Metformin HCl; Metformin hydrochloride; Metformina; Metformine | 1件: D04966
D04966
| 2件: PRKAA1 PRKAA1,
PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 |
| 9 |
Ranibizumab
| 3件: Lucentis Lucentis; RANIBIZUMAB; RhuFab V2 | 1件: D05697
D05697
| 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 4件: 34 34, 166, 227, 301 |
| 10 |
Sildenafil
| 6件: Mysildecard Mysildecard; REVATIO; Sildenafil; SILDENAFIL CITRATE; SILDENAFILO; VIAGRA | 1件: D08514
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
| 11 |
STG-001
| 1件: STG-001 STG-001 | - | - | - | 1件: 301 301 |